RapidAI

RapidAI is the world's leading advanced stroke imaging technology research company. Its artificial intelligence-powered Rapid Imaging Platform, including Rapid CTP, Rapid MRI, Rapid CTA, Rapid ICH, and Rapid ASPECTS, has been installed in over 1,500 hospitals across more than 50 countries. RapidAI enables clinicians to leverage clinically validated, data-driven technology to make faster and more accurate diagnostic and treatment decisions for stroke patients. Through an effective and trusted platform developed by stroke experts, clinicians worldwide are improving patient care and outcomes daily. The Rapid platform has been proven to assist in patient selection during early and late-phase clinical stroke trials. In addition to achieving optimal clinical outcomes and maximizing treatment efficacy, the results of these trials have led to new treatment guidelines from the American Heart Association and the American Stroke Association, significantly transforming the management of acute stroke worldwide.